Boryung Pharm (003850) — Capital Reinvestment Ratio
Boryung Pharm (003850) has a Capital Reinvestment Ratio of 0.10x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩48.95 Billion) in capital expenditures (₩4.92 Billion). See 003850 net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Boryung Pharm Capital Reinvestment Ratio (2009–2024)
This chart tracks Boryung Pharm's Capital Reinvestment Ratio across 12 annual periods. Check how aggressively does Boryung Pharm reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Boryung Pharm (2009–2024)
Year-by-year Capital Reinvestment Ratio for Boryung Pharm from 2009 to 2024. For live market cap and broader valuation context, see market value of Boryung Pharm.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.25x | ₩80.56 Billion | ₩20.05 Billion | ▼ -55.0% |
| 2023 | 0.55x | ₩42.22 Billion | ₩23.35 Billion | ▼ -24.1% |
| 2022 | 0.73x | ₩27.81 Billion | ₩20.28 Billion | ▲ +171.9% |
| 2021 | 0.27x | ₩60.17 Billion | ₩16.13 Billion | ▼ -34.3% |
| 2020 | 0.41x | ₩44.74 Billion | ₩18.27 Billion | ▼ -71.4% |
| 2019 | 1.43x | ₩47.00 Billion | ₩67.02 Billion | ▲ +1.2% |
| 2018 | 1.41x | ₩38.91 Billion | ₩54.83 Billion | ▼ -50.8% |
| 2016 | 2.87x | ₩9.36 Billion | ₩26.83 Billion | ▲ +427.9% |
| 2012 | 0.54x | ₩18.38 Billion | ₩9.98 Billion | ▼ -64.8% |
| 2011 | 1.54x | ₩9.19 Billion | ₩14.16 Billion | ▲ +24.9% |
| 2010 | 1.23x | ₩24.12 Billion | ₩29.77 Billion | ▼ -60.7% |
| 2009 | 3.14x | ₩3.59 Billion | ₩11.28 Billion | — |